methyl 3-methyl-4H-1,4-benzothiazine-2-carboxylate结构式
|
常用名 | methyl 3-methyl-4H-1,4-benzothiazine-2-carboxylate | 英文名 | methyl 3-methyl-4H-1,4-benzothiazine-2-carboxylate |
|---|---|---|---|---|
| CAS号 | 90252-61-2 | 分子量 | 221.27600 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C11H11NO2S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
本表展示该化学物质的中文名称、英文系统名、各类中文与英文别名信息。
| 英文名 | methyl 3-methyl-4H-1,4-benzothiazine-2-carboxylate |
|---|---|
| 英文别名 | 更多 |
本表包含该物质理化参数,如熔点、沸点、密度、溶解度、旋光性等理化指标,无数据项标记为N/A。
| 分子式 | C11H11NO2S |
|---|---|
| 分子量 | 221.27600 |
| 精确质量 | 221.05100 |
| PSA | 63.63000 |
| LogP | 2.74670 |
| InChIKey | HABUAUOEGULWTO-UHFFFAOYSA-N |
| SMILES | COC(=O)C1=C(C)Nc2ccccc2S1 |
本表提供该化合物公开报道的合成路线、反应条件、反应物与产物参考信息。
|
~28%
methyl 3-methyl... 90252-61-2 |
| 文献:Foster, Robert; Gilchrist, Thomas L. Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1991 , # 9 p. 2249 - 2254 |
|
~87%
methyl 3-methyl... 90252-61-2 |
| 文献:More; Mahulikar Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2011 , vol. 50, # 5 p. 745 - 747 |
|
~57%
methyl 3-methyl... 90252-61-2 |
| 文献:Gupta, R. R.; Jain, S. K.; Gupta, Vandana; Rathore, R. K. Zeitschrift fuer Naturforschung, B: Chemical Sciences, 1989 , vol. 44, # 9 p. 1124 - 1126 |
本表记录该化合物靶点、体外体内实验、生物测定实验相关实验数据。
|
实验名称:A screen for compounds that inhibit cell wall-associated teichoic acid synthesis in S...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS704
|
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|
|
实验名称:Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:ORF 73 [Human herpesvirus 8 type M]
External Id:HMS791
|
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|
|
实验名称:A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS979
|
|
实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify activators of...
来源:The Scripps Research Institute Molecular Screening Center
靶标:N/A
External Id:FBW7_ACT_ALPHA_1536_1X%ACT PRUN
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源:The Scripps Research Institute Molecular Screening Center
External Id:MITF_INH_Alpha_1536_1X%INH PRUN
|
|
实验名称:A screen for compounds that inhibit viral RNA polymerase binding and polymerization a...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:Chain A, Poliovirus Polymerase With Gtp
External Id:HMS750
|
本表罗列该化合物全部英文别名、系统命名、CAS别名等英文名称集合。
| hms1676p10 |
本部分为该化合物相关常见问答,包含基础参数、性状、储存条件等高频咨询问题与对应答案。
| Q: 90252-61-2有哪些英文别名? |
| A: 90252-61-2英文别名有:hms1676p10。 |
| Q: 90252-61-2的SMILES表达式是什么? |
| A: 90252-61-2SMILES表达式为COC(=O)C1=C(C)Nc2ccccc2S1。 |
| Q: 90252-61-2的LogP(油水分配系数)是多少? |
| A: 90252-61-2LogP(油水分配系数)为2.74670。 |
| Q: 90252-61-2的英文名称是什么? |
| A: 90252-61-2英文名称为methyl 3-methyl-4H-1,4-benzothiazine-2-carboxylate。 |
| Q: 90252-61-2的极性表面积PSA是多少? |
| A: 90252-61-2极性表面积PSA为63.63000。 |
| Q: 90252-61-2的CAS号是多少? |
| A: 90252-61-2CAS号为90252-61-2。 |
| Q: 90252-61-2的中文名称是什么? |
| A: 90252-61-2的中文名称为90252-61-2。 |
| Q: 90252-61-2的分子量是多少? |
| A: 90252-61-2分子量为221.27600。 |
| Q: 90252-61-2的InChIKey是什么? |
| A: 90252-61-2InChIKey为HABUAUOEGULWTO-UHFFFAOYSA-N。 |
| Q: 90252-61-2的分子式是什么? |
| A: 90252-61-2分子式为C11H11NO2S。 |